Ratings by Brookline Capital Markets (Kumaraguru Raja)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/21/2021 Dermata Therapeutics In DRMA New Coverage Buy
(N/A)
4.87
(5.16)
5.95% Details
9/3/2021 Forte Biosciences Inc. FBRX Downgrade Hold
(Buy)
28.59
(3.24)
-88.67% Details
8/24/2021 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
8/3/2021 Outlook Therapeutics Incs. OTLK Maintain Buy
(N/A)
 
 
  Details
7/29/2021 Atreca Inc. BCEL Maintain Buy
(N/A)
 
 
  Details
5/19/2021 Veru, Inc. VERU Maintain Buy
(N/A)
 
 
  Details
3/25/2021 9 Meter Biopharma NMTR New Coverage Buy
(N/A)
1.31
(1.33)
1.53% Details
3/24/2021 Forte Biosciences Inc. FBRX Maintain Buy
(N/A)
 
 
  Details
3/23/2021 Hepion Pharma HEPA Maintain Buy
(N/A)
 
 
  Details
3/12/2021 NLS Pharmaceutics NLSP New Coverage Buy
(N/A)
2.82
(2.59)
-8.16% Details
3/4/2021 Vaxart Inc. VXRT Maintain Buy
(N/A)
 
 
  Details
3/3/2021 Caladrius Biosciences CLBS Maintain Buy
(N/A)
 
 
  Details
2/23/2021 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
2/12/2021 Veru, Inc. VERU Maintain Buy
(N/A)
 
 
  Details
2/2/2021 CNS Pharmasceuticals Inc. CNSP New Coverage Buy
(N/A)
1.80
(1.49)
-17.22% Details
12/29/2020 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
12/11/2020 Veru, Inc. VERU Maintain Buy
(N/A)
 
 
  Details
12/7/2020 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
8/28/2020 Forte Biosciences Inc. FBRX New Coverage Buy
(N/A)
26.69
(3.24)
-87.86% Details
8/20/2020 FSD Pharma Inc HUGE New Coverage Buy
(N/A)
2.76
(1.54)
-44.2% Details
8/13/2020 BioCardiAa BCDA Maintain Buy
(N/A)
 
 
  Details
7/15/2020 Celsion Corp CLSN Maintain Buy
(N/A)
 
 
  Details
5/22/2020 Caladrius Biosciences CLBS New Coverage Buy
(N/A)
1.93
(1.22)
-36.79% Details
5/19/2020 Cyclacel Pharmaceuticals CYCC New Coverage Buy
(N/A)
4.12
(5.40)
31.07% Details
5/11/2020 Arcturus Therapeutics ARCT Maintain Buy
(N/A)
 
 
  Details
3/30/2020 Edesa Biotech Inc. EDSA New Coverage Buy
(N/A)
2.16
(8.15)
277.31% Details
3/13/2020 Armata Pharmaceuticals ARMP New Coverage Buy
(N/A)
3.20
(3.64)
13.75% Details
2/13/2020 Veru, Inc. VERU Maintain Buy
(N/A)
 
 
  Details
1/9/2020 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
1/8/2020 SCYNEXIS SCYX Maintain Buy
(N/A)
 
 
  Details
11/26/2019 BioCardia BCDA New Coverage Buy
(N/A)
3.51
(3.35)
-4.56% Details
11/22/2019 Hepion Pharma HEPA New Coverage Buy
(N/A)
3.39
(1.55)
-54.28% Details
11/11/2019 Chiasma CHMA Maintain Buy
(N/A)
 
 
  Details
8/20/2019 Atreca Inc. BCEL New Coverage Hold
(N/A)
17.60
(6.71)
-61.88% Details
8/20/2019 SCYNEXIS SCYX New Coverage Buy
(N/A)
1.08
(5.58)
416.67% Details
8/15/2019 Vaxart Inc. VXRT New Coverage Buy
(N/A)
0.67
(8.18)
1120.9% Details
7/30/2019 Cellectar Biosciences CLRB New Coverage Buy
(N/A)
2.15
(0.98)
-54.42% Details
7/30/2019 Veru, Inc. VERU New Coverage Buy
(N/A)
2.28
(9.07)
297.81% Details
7/30/2019 Progenics Pharmaceuticals PGNX New Coverage Buy
(N/A)
5.18
(4.10)
-20.85% Details
7/25/2019 Celsion Corp CLSN New Coverage Buy
(N/A)
1.77
(1.01)
-42.94% Details
7/25/2019 Chiasma CHMA New Coverage Buy
(N/A)
7.86
(3.79)
-51.78% Details
2/6/2019 Chiasma CHMA New Coverage Buy
(N/A)
3.42
(7.86)
129.82% Details
11/28/2018 Rexahn Pharmaceuticals Inc. RNN New Coverage Buy
(N/A)
1.11
(5.24)
372.07% Details
11/21/2018 Cellectar Biosciences CLRB New Coverage Buy
(N/A)
2.20
(2.15)
-2.27% Details
11/20/2018 Celsion Corp CLSN New Coverage Buy
(N/A)
1.88
(1.77)
-5.85% Details
8/15/2018 Acer Therapeutics ACER Maintain Buy
(N/A)
 
 
  Details